Rick E. Winningham, Chief Executive Officer at Theravance Biopharma, Inc. (TBPH), bought 80,000 shares at $11.79 ($949K) on 2015-08-14, disclosed to the SEC on 2015-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.79 | 63,140 | $744K | 78.4% |
| 2 | $12.13 | 16,860 | $205K | 21.6% |
| Total | $11.86 avg | 80,000 | $949K | 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |